Background: Onchocerciasis has been implicated in the pathogenesis of epilepsy. The debate on a potential causal relationship between Onchocerca volvulus and epilepsy has taken a new direction in the light of the most recent epidemic of nodding syndrome. Objective: To document MRI changes in people with different types of epilepsy and investigate whether there is an association with O. volvulus infection. Methods: In a prospective study in southern Tanzania, an area endemic for O. volvulus with a high prevalence of epilepsy and nodding syndrome, we performed MRI on 32 people with epilepsy, 12 of which suffered from nodding syndrome. Polymerase chain reaction (PCR) of O. volvulus was performed in skin and CSF. Results: The most frequent abnormalities seen on MRI was atrophy (twelve patients (37.5%)) followed by intraparenchymal pathologies such as changes in the hippocampus (nine patients (28.1%)), gliotic lesions (six patients (18.8%)) and subcortical signal abnormalities (three patients (9.4%)). There was an overall trend towards an association of intraparenchymal cerebral pathologies and infection with O. volvulus based on skin PCR (Fisher's Exact Test p=0.067) which was most pronounced in children and adolescents with nodding syndrome compared to those with other types of epilepsy (Fisher's Exact Test, p=0.083). Contrary to skin PCR results, PCR of CSF was negative in all patients. Conclusion: The observed trend towards an association of intraparenchymal cerebral pathological results on MRI and a positive skin PCR for O. volvulus despite negative PCR of CSF is intriguing and deserves further attention.

Our results do not give evidence of a relationship between O. volvulus and epilepsy. Despite the fact that 2 participants had raised antibody index, the existence of cerebral onchocerciasis caused by migration of microfilariae into the CSF appears unlikely. However, to date unexplored reactions to the infestation with O. volvulus causing epilepsy cannot be excluded.

We have previously described a seizure disorder characterized by head nodding (HN). In a prospective study in southern Tanzania, we evaluated 62 patients with HN. Here, we report the patients' clinical characteristics and those of their seizures, which indicate high seizure frequency, unsatisfactory seizure control, a high burden of cognitive impairment and disease-associated barriers to education.

Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine involved in systemic, autoimmune, and inflammatory diseases, such as obesity, rheumatoid arthritis, and systemic lupus erythematosus. For the 2 past decades, MIF has been reported to participate in carcinogenesis, disease prognosis, tumor cell proliferation, invasion, and tumor-induced angiogenesis in many cancers. The purpose of this article is to review published experimental and clinical data for MIF and its involvement in upper aerodigestive tract cancers. Based on the current literature, we propose a biomolecular model describing the mechanisms underlying the involvement of MIF in the initiation, progression, apoptosis, and proliferation of head and neck tumor cells. In reference to this model, potential therapeutic approaches based on the use of MIF antagonists and neutralizing antibodies are described. It is concluded that MIF is a promising target for future therapeutic strategies, both with and without chemoradiation strategies.

Zusammenfassung Hintergrund Die bilaterale Medialis-Rücklagerung (BMR) ist ein häufig angewendetes Verfahren zur Behandlung von frühkindlichen Esotropien mit kleineren und größeren Schielwinkeln. Ziel unserer Studie ist die Ermittlung der Dosis-Wirkungs-Beziehung und des Therapieerfolgs. Design Retrospektive, monozentrische klinische Studie mit demselben Operateur. Methode 60 Patienten mit frühkindlicher Esotropie, die eine reine BMR mittels einer mikroinvasiven Technik von April 2012 bis September 2015 erhielten, wurden ausgewertet. Erfasst wurden die prä- und postoperativen Daten nach 3, 12 und 36 Monaten. Als Behandlungserfolg wurde ein Restschielwinkel von ≤ ± 10 Prismendioptrien (PD) beim Follow-up nach 12 Monaten oder ein nachweisbar positives Simultansehen definiert. Ergebnisse Das Alter zum OP-Zeitpunkt lag bei 5,2 ± 4,6 (Median ± SD) Jahren. Der präoperative Schielwinkel in der Ferne betrug 41 ± 10,5 PD und in der Nähe 44 ± 11 PD. Die mittlere Refraktion (sphärisches Äquivalent) betrug + 2,25 dpt. Der postoperative Fernwinkel (n = 58) im 12-Monats-Follow-up betrug 6 ± 9,6 PD und nach 36 Monaten (n = 38) 4 ± 10,5 PD. Die Schielwinkelreduktion pro mm im 12-Monats-Follow-up betrug 3,08 ± 1,20 PD und im 36-Monats-Follow-up 3,18 ± 1,27 PD. Die Schielwinkelreduktion pro mm bei Patienten ≤ 4 Jahren lag bei 3,93 ± 1,86 PD und > 4 Jahren bei 2,81 ± 0,98 PD. Der Therapieerfolg nach dem 12-Monats-Follow-up lag bei 67%. Positives Simultansehen konnte postoperativ bei 62% nachgewiesen werden. Schlussfolgerung Die BMR ist eine langfristige, effiziente Methode zur Behandlung der frühkindlichen Esotropie. Die mittlere Dosis-Wirkungs-Beziehung nach 36 Monaten lag bei 3,1 PD pro mm.